Abstract

<h3>Objective:</h3> To investigate the relationship between cognition and white matter (WM) in relapsing remitting (RRMS) patients. <h3>Background:</h3> Cognition is thought to be mainly associated with gray matter injury in MS. The role of WM tracts in MS-cognitive impairment is still uncertain. <h3>Design/Methods:</h3> Thirty RRMS patients were recruited and underwent the 3-seconds-interstimulus interval paced auditory serial addition test (PASAT-3), symbol digit modalities test (SDMT), and whole brain MRI scan on a SIEMENS 3 Tesla Verio scanner. Diffusion tensor imaging (DTI) metrics including fractional anisotropy (FA) and mean diffusivity (MD) were measured in 37 WM regions selected from association, projection, and commissural pathways, by applying Human Connectome Project (HCP)842 tractography atlas after DTI data reconstruction and registration to HCP1065 diffusion template were performed in DSI Studio (version March 2021). Spearman’s rank correlation analysis was performed to investigate the relationship between DTI WM tracts and cognitive scores in SPSS v26. False discovery rate (FDR) calculation was done to decrease the false positives and increase the power of the study. <h3>Results:</h3> Mean PASAT-3 and SDMT scores were 31.5 ±12.8 and 46.9 ±16.7 respectively. Higher FA values were associated with better cognitive function, while higher MD values were associated with worse cognitive function. FA values in right medial lemniscus and superior cerebellar peduncle were positively correlated with SDMT scores (p&lt;0.05), while a strong trend for significance was found for the left corticothalamic tract (p=0.05). MD values of the superior cerebellar peduncle, left arcuate fasciculus and left extreme capsule were negatively correlated with SDMT scores (p&lt;0.05), while MD value of the right cerebellum was negatively correlated with PASAT-3 score. No significant correlation was found between FA values and PASAT-3 scores. <h3>Conclusions:</h3> Our data support the contribution of certain WM tracts to the cognitive impairment in RRMS. Longitudinal studies with larger samples are warranted. <b>Disclosure:</b> Mr. Elkhooly has nothing to disclose. Fen Bao has nothing to disclose. Mr. Lazar has nothing to disclose. Miss Azo has nothing to disclose. Dr. Reyes has nothing to disclose. Dr. Srivastava has nothing to disclose. Ms. Pelc has nothing to disclose. Mrs. Casiglia has nothing to disclose. Dr. Rube has nothing to disclose. Dr. Raghib has nothing to disclose. Ms. Santiago-Martinez has nothing to disclose. Mr. Khan has nothing to disclose. Dr. Bernitsas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen@Janssen. Dr. Bernitsas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Bernitsas has received research support from Roche/Genentech.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call